Bonifazi, Francesca <br/><br/>
Acute GVHD prophylaxis plus ATLG after myeloablative allogeneic haemopoietic peripheral blood stem-cell transplantation from HLA-identical siblings in patients with acute myeloid leukaemia in remission: final results of quality of life and long-term outcome analysis of a phase 3 randomised study.  [electronic resource] 

 -  The Lancet. Haematology  Feb 2019 
 - e89-e99 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>2352-3026 
<br/><br/><label>Standard No.: </label>10.1016/S2352-3026(18)30214-X  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Antilymphocyte Serum--immunology<br/>Disease-Free Survival<br/>Female<br/>Graft vs Host Disease--etiology<br/>HLA Antigens--metabolism<br/>Hematopoietic Stem Cell Transplantation--adverse effects<br/>Humans<br/>Leukemia, Myeloid, Acute--immunology<br/>Male<br/>Middle Aged<br/>Quality of Life<br/>Siblings<br/>Young Adult